ENHANC3D GENOMICS

ENHANC3D GENOMICS is a pioneering force in biotechnology research, dedicated to transforming therapeutic development through the power of functional genomics. ENHANC3D GENOMICS focuses on creating innovative applications to improve human healthcare outcomes, positioning itself as a key player in the biotechnology sector.

Based in Cambridge, UK, with a primary address at Milner Therapeutics Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Puddicombe Way Cambridge, CB20 0AW, GB, ENHANC3D GENOMICS utilizes disruptive technology to profile 3D genome folding at high resolution. This enables the simultaneous linking of gene enhancers and non-coding genetic variants to their target genes, unlocking new potentials for therapeutic discovery. ENHANC3D GENOMICS is at the forefront of regulatory genomics and chromosomal architecture.

ENHANC3D GENOMICS is committed to advancing the frontiers of biotechnology. We invite the management team at ENHANC3D GENOMICS to take advantage of our platform to create a customized and exclusive company showcase and product listing, further enhancing their commercial development.